Chemomab Therapeutics Ltd DRC (CMMB)

Chemomab Therapeutics Ltd DRC (CMMB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $8.4M; returns 1 day -4.6%, 1 week -18.6%, 1 year -64.6%.

Chemomab Therapeutics Ltd. (CMMB) is a clinical-stage biotechnology company based in Tel Aviv, Israel, dedicated to the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet needs.

Groups CMMB belongs to

• Clinical Stage Biotech
• Israel Companies
• Biotechnology
• Israel
• Fibrosis
• Monoclonal Antibodies
• Healthcare
• Rare Diseases
• Clinical Stage

CMMB financial model: income statement, cash flow and balance sheet